Utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as biomarker to predict therapeutic response to methotrexate in rheumatoid arthritis. [electronic resource]
Producer: 20180524Description: 606-614 p. digitalISSN:- 1753-4267
- Adult
- Aged
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- diagnosis
- Biomarkers, Pharmacological -- metabolism
- Cohort Studies
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Predictive Value of Tests
- Prognosis
- Prospective Studies
- Sensitivity and Specificity
- Surveys and Questionnaires
- Triggering Receptor Expressed on Myeloid Cells-1 -- metabolism
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.